Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States

Effect of Teriparatide on Bone Formation in the Human Femoral Neck

(2016) Felicia Cosman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Association between teriparatide treatment persistence and adherence, and fracture incidence in Taiwan: analysis using the National Health Insurance Research Database

(2016) D.-C. Chan et al.   OSTEOPOROSIS INTERNATIONAL

Osteoporotic fractures and associated hospitalizations among patients treated with teriparatide compared to a matched cohort of patients not treated with teriparatide

(2015) Natalie Boytsov et al.   CURRENT MEDICAL RESEARCH AND OPINION

Teriparatide fracture effectiveness in the real world

(2015) J. H. Krege et al.   OSTEOPOROSIS INTERNATIONAL

Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis

(2015) M. M. Bonafede et al.   OSTEOPOROSIS INTERNATIONAL

Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States

(2015) Lung-I Cheng et al.   Journal of Managed Care & Specialty Pharmacy

Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis

(2014) Erik F. Eriksen et al.   BONE

The Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) study: 2-year nonvertebral fragility fracture results

(2013) S. Silverman et al.   OSTEOPOROSIS INTERNATIONAL

Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data

(2012) Jeffrey R. Curtis et al.   ARTHRITIS CARE & RESEARCH

The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women

(2011) Robert B Hopkins et al.   BMC MUSCULOSKELETAL DISORDERS

The Association between Statin use and Outcomes Potentially Attributable to an Unhealthy Lifestyle in Older Adults

(2011) Amanda R. Patrick et al.   VALUE IN HEALTH

Which fractures are most attributable to osteoporosis?

(2010) Amy H. Warriner et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance

(2010) S. A. Foster et al.   OSTEOPOROSIS INTERNATIONAL

Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors

(2010) S. M. Cadarette et al.   OSTEOPOROSIS INTERNATIONAL

Epidemiology of hip fractures in Austria: evidence for a change in the secular trend

(2010) H. P. Dimai et al.   OSTEOPOROSIS INTERNATIONAL

Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe

(2009) Ethel S. Siris et al.   AMERICAN JOURNAL OF MEDICINE

Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS)

(2009) Bente L. Langdahl et al.   CALCIFIED TISSUE INTERNATIONAL

Incidence and Mortality of Hip Fractures in the United States

(2009) Carmen A. Brauer   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Trends in Hip Fracture Rates in Canada

(2009) William D. Leslie   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Optimal Internal Fixation for Femoral Neck Fractures: Multiple Screws or Sliding Hip Screws?

(2009) Mohit Bhandari et al.   JOURNAL OF ORTHOPAEDIC TRAUMA

Identification and Validation of Vertebral Compression Fractures Using Administrative Claims Data

(2008) Jeffrey R. Curtis et al.   MEDICAL CARE

Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis

(2008) R. Lindsay et al.   OSTEOPOROSIS INTERNATIONAL